87 related articles for article (PubMed ID: 21397613)
1. Protective role of adiponectin on endothelial dysfunction induced by AGEs: a clinical and experimental approach.
Del Turco S; Navarra T; Gastaldelli A; Basta G
Microvasc Res; 2011 Jul; 82(1):73-6. PubMed ID: 21397613
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
[TBL] [Abstract][Full Text] [Related]
3. Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men.
Sjögren P; Basta G; de Caterina R; Rosell M; Basu S; Silveira A; de Faire U; Vessby B; Hamsten A; Hellenius ML; Fisher RM
Atherosclerosis; 2007 Dec; 195(2):e168-75. PubMed ID: 17655851
[TBL] [Abstract][Full Text] [Related]
4. Serum advanced glycation end products (AGEs) are associated with insulin resistance.
Tan KC; Shiu SW; Wong Y; Tam X
Diabetes Metab Res Rev; 2011 Jul; 27(5):488-92. PubMed ID: 21337488
[TBL] [Abstract][Full Text] [Related]
5. Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway.
Lee WJ; Wu CS; Lin H; Lee IT; Wu CM; Tseng JJ; Chou MM; Sheu WH
Int J Obes (Lond); 2009 Apr; 33(4):465-72. PubMed ID: 19223849
[TBL] [Abstract][Full Text] [Related]
6. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.
Xu B; Chibber R; Ruggiero D; Kohner E; Ritter J; Ferro A
FASEB J; 2003 Jul; 17(10):1289-91. PubMed ID: 12738813
[TBL] [Abstract][Full Text] [Related]
7. Impact of diabetic serum on endothelial cells: an in-vitro-analysis of endothelial dysfunction in diabetes mellitus type 2.
Münzel D; Lehle K; Haubner F; Schmid C; Birnbaum DE; Preuner JG
Biochem Biophys Res Commun; 2007 Oct; 362(2):238-44. PubMed ID: 17709096
[TBL] [Abstract][Full Text] [Related]
8. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
[TBL] [Abstract][Full Text] [Related]
9. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance.
Caballero AE; Bousquet-Santos K; Robles-Osorio L; Montagnani V; Soodini G; Porramatikul S; Hamdy O; Nobrega AC; Horton ES
Diabetes Care; 2008 Mar; 31(3):576-82. PubMed ID: 18083792
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products.
Kunt T; Forst T; Wilhelm A; Tritschler H; Pfuetzner A; Harzer O; Engelbach M; Zschaebitz A; Stofft E; Beyer J
Clin Sci (Lond); 1999 Jan; 96(1):75-82. PubMed ID: 9857109
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.
Lieuw-A-Fa ML; van Hinsbergh VW; Teerlink T; Barto R; Twisk J; Stehouwer CD; Schalkwijk CG
Nephrol Dial Transplant; 2004 Mar; 19(3):631-6. PubMed ID: 14767019
[TBL] [Abstract][Full Text] [Related]
14. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
16. Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M
Int J Tissue React; 2005; 27(4):189-95. PubMed ID: 16440584
[TBL] [Abstract][Full Text] [Related]
17. Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines.
Stirban A; Negrean M; Götting C; Uribarri J; Gawlowski T; Stratmann B; Kleesiek K; Koschinsky T; Vlassara H; Tschoepe D
Ann N Y Acad Sci; 2008 Apr; 1126():276-9. PubMed ID: 18448830
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Wu JM; Ma YB; You BA; Li BY; Xuan JH
J Cardiovasc Pharmacol; 2006 Aug; 48(2):47-53. PubMed ID: 16954821
[TBL] [Abstract][Full Text] [Related]
19. Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators.
Meng D; Liu N
Chin Med J (Engl); 2003 Sep; 116(9):1336-40. PubMed ID: 14527361
[TBL] [Abstract][Full Text] [Related]
20. The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules.
Kunt T; Forst T; Harzer O; Buchert G; Pfützner A; Löbig M; Zschäbitz A; Stofft E; Engelbach M; Beyer J
Exp Clin Endocrinol Diabetes; 1998; 106(3):183-8. PubMed ID: 9710358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
